CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,386,358 | -6.4% | 5,274,486 | +3.6% | 0.01% | 0.0% |
| Q2 2023 | $166,087,340 | -0.7% | 5,091,580 | +7.1% | 0.01% | 0.0% |
| Q1 2023 | $167,289,741 | -63.8% | 4,753,900 | -52.9% | 0.01% | -35.7% |
| Q4 2022 | $462,315,918 | +124.2% | 10,089,828 | +137.1% | 0.01% | +7.7% |
| Q3 2022 | $206,161,000 | +16.5% | 4,255,125 | -5.5% | 0.01% | +18.2% |
| Q2 2022 | $176,971,000 | +14.6% | 4,504,226 | +7.3% | 0.01% | +37.5% |
| Q1 2022 | $154,485,000 | -15.0% | 4,196,832 | +5.3% | 0.01% | -11.1% |
| Q4 2021 | $181,647,000 | +17.9% | 3,985,227 | -7.5% | 0.01% | +12.5% |
| Q3 2021 | $154,050,000 | +83.1% | 4,310,288 | +1.4% | 0.01% | +100.0% |
| Q2 2021 | $84,123,000 | -12.7% | 4,250,786 | +2.6% | 0.00% | -33.3% |
| Q1 2021 | $96,342,000 | -0.1% | 4,141,970 | -10.8% | 0.01% | 0.0% |
| Q4 2020 | $96,438,000 | +17.8% | 4,640,923 | +22.8% | 0.01% | 0.0% |
| Q3 2020 | $81,843,000 | +14.2% | 3,780,260 | +24.3% | 0.01% | +20.0% |
| Q2 2020 | $71,677,000 | +126.4% | 3,041,032 | +13.2% | 0.01% | +66.7% |
| Q1 2020 | $31,663,000 | +17.5% | 2,685,562 | +5.7% | 0.00% | +50.0% |
| Q4 2019 | $26,947,000 | +2.0% | 2,539,766 | +9.4% | 0.00% | 0.0% |
| Q3 2019 | $26,412,000 | -2.8% | 2,320,879 | -4.0% | 0.00% | 0.0% |
| Q2 2019 | $27,186,000 | +64.6% | 2,416,514 | +18.3% | 0.00% | +100.0% |
| Q1 2019 | $16,520,000 | +36.4% | 2,042,077 | +6.6% | 0.00% | 0.0% |
| Q4 2018 | $12,109,000 | -38.6% | 1,915,962 | -4.3% | 0.00% | -50.0% |
| Q3 2018 | $19,717,000 | +16.1% | 2,001,562 | -2.1% | 0.00% | +100.0% |
| Q2 2018 | $16,978,000 | -0.2% | 2,045,301 | -13.4% | 0.00% | 0.0% |
| Q1 2018 | $17,005,000 | -23.2% | 2,361,612 | -13.0% | 0.00% | -50.0% |
| Q4 2017 | $22,139,000 | -16.8% | 2,715,972 | +48.0% | 0.00% | 0.0% |
| Q3 2017 | $26,615,000 | +31.4% | 1,835,515 | +9.6% | 0.00% | 0.0% |
| Q2 2017 | $20,259,000 | +69.1% | 1,674,335 | +79.6% | 0.00% | +100.0% |
| Q1 2017 | $11,981,000 | +9.8% | 932,426 | +3.9% | 0.00% | 0.0% |
| Q4 2016 | $10,908,000 | +22.1% | 897,748 | -7.8% | 0.00% | 0.0% |
| Q3 2016 | $8,936,000 | +51.2% | 973,200 | +56.2% | 0.00% | 0.0% |
| Q2 2016 | $5,911,000 | +53.7% | 623,246 | +14.3% | 0.00% | – |
| Q1 2016 | $3,845,000 | -54.1% | 545,460 | -31.9% | 0.00% | -100.0% |
| Q4 2015 | $8,380,000 | +127.2% | 801,211 | +45.4% | 0.00% | – |
| Q3 2015 | $3,689,000 | -0.1% | 551,038 | +0.3% | 0.00% | – |
| Q2 2015 | $3,694,000 | +1.8% | 549,615 | +2.7% | 0.00% | – |
| Q1 2015 | $3,629,000 | -11.0% | 535,333 | +5.1% | 0.00% | – |
| Q4 2014 | $4,079,000 | +129.5% | 509,167 | +1.1% | 0.00% | – |
| Q3 2014 | $1,777,000 | -24.7% | 503,490 | +2.1% | 0.00% | – |
| Q2 2014 | $2,360,000 | -49.2% | 493,368 | +0.9% | 0.00% | -100.0% |
| Q1 2014 | $4,648,000 | +72.1% | 489,174 | +9.2% | 0.00% | – |
| Q4 2013 | $2,701,000 | -5.9% | 447,932 | +18.6% | 0.00% | – |
| Q3 2013 | $2,869,000 | -14.1% | 377,687 | +30.8% | 0.00% | – |
| Q2 2013 | $3,340,000 | – | 288,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,106,989 | $14,159,000 | 2.50% |
| Healthcare Value Capital, LLC | 100,000 | $672,000 | 0.71% |
| First Light Asset Management, LLC | 218,792 | $1,470,000 | 0.69% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 435,202 | $2,925,000 | 0.67% |
| TFS CAPITAL LLC | 899,951 | $6,048,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,250 | $2,838,000 | 0.28% |
| ALGERT GLOBAL LLC | 73,181 | $492,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $15,603,000 | 0.13% |
| Leisure Capital Management | 17,567 | $118,000 | 0.12% |
| Rotella Capital Management, Inc. | 15,778 | $106,000 | 0.09% |